ARTICLE
FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression
The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).
YOU MIGHT ALSO LIKE
CLEAR ALL